ClinConnect ClinConnect Logo
Search / Trial NCT06885411

Ototoxicity in Patients With MoM Hip Bearings

Launched by REINIER HAGA ORTHOPEDISCH CENTRUM · Mar 17, 2025

Trial Information

Current as of April 29, 2025

Recruiting

Keywords

Metal On Metal Implant; Cobalt; Chromium; Hip Arthroplasty; Auditory System; Otoxicity

ClinConnect Summary

This clinical trial is studying the effects of metal-on-metal (MoM) hip implants on hearing loss. Researchers want to find out how common hearing loss is in patients who have these hip replacements, especially looking at the levels of metals like cobalt and chromium in their blood. By understanding the relationship between these metal levels and hearing loss, the study aims to improve patient care for those with MoM hip implants.

To participate in this study, you need to have a MoM hip implant, either new or revised, and be willing to take part in the research. You should also be able to speak and write in Dutch. However, if you have had previous ear surgeries or have other specific ear-related health issues, you won’t be eligible for this study. If you join, you can expect regular check-ins to monitor your hearing and blood metal levels, helping researchers gather important information about the safety of MoM hip implants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • all MoM patients from the different clinics
  • revision MoM
  • willing to participate
  • speak/write the Dutch language
  • Exclusion Criteria:
  • Not willing to participate
  • previous ENT surgery or ENT pathology

About Reinier Haga Orthopedisch Centrum

Reinier Haga Orthopedisch Centrum is a leading orthopedic center dedicated to advancing musculoskeletal care through innovative clinical trials and research. Committed to improving patient outcomes, the center specializes in a wide range of orthopedic conditions and employs a multidisciplinary approach to treatment. With a focus on evidence-based practices, the Reinier Haga Orthopedisch Centrum collaborates with healthcare professionals and researchers to develop and evaluate new therapies, ultimately enhancing the quality of care provided to patients.

Locations

Delft, , Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported